Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia
一项多中心、单盲、随机对照研究，旨在评估法匹拉韦和萘莫司他甲磺酸盐治疗COVID-19肺炎患者的疗效和安全性。
期刊:International Journal of Infectious Diseases
影响因子:4.3
doi:10.1016/j.ijid.2022.12.039
Ikeda, Mahoko; Okugawa, Shu; Kashiwabara, Kosuke; Moritoyo, Takashi; Kanno, Yoshiaki; Jubishi, Daisuke; Hashimoto, Hideki; Okamoto, Koh; Tsushima, Kenji; Uchida, Yasuki; Mitsumura, Takahiro; Igari, Hidetoshi; Tsutsumi, Takeya; Araoka, Hideki; Yatera, Kazuhiro; Yamamoto, Yoshihiro; Nakamura, Yuki; Otani, Amato; Yamashita, Marie; Wakimoto, Yuji; Shinohara, Takayuki; Adachi-Katayama, Maho; Oyabu, Tatsunori; Kanematsu, Aoi; Harada, Sohei; Takeshita, Yuichiro; Nakano, Yasutaka; Miyazaki, Yasunari; Sakao, Seiichiro; Saito, Makoto; Ogura, Sho; Yamasaki, Kei; Kawasuji, Hitoshi; Hataji, Osamu; Inoue, Jun-Ichiro; Seto, Yasuyuki; Moriya, Kyoji
